First Time Loading...

Modalis Therapeutics Corp
TSE:4883

Watchlist Manager
Modalis Therapeutics Corp Logo
Modalis Therapeutics Corp
TSE:4883
Watchlist
Price: 70 JPY -1.41% Market Closed
Updated: May 16, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

1.6B
-23%
Assets
Growth Rates:
1 Year
-46%
3 Years
-76%
5 Years
-
7 Years
-
10 Years
-
547.5m
-15%
Liabilities
Growth Rates:
1 Year
+123%
3 Years
+430%
5 Years
-
7 Years
-
10 Years
-
1B
-27%
Equity
Growth Rates:
1 Year
-62%
3 Years
-84%
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
Modalis Therapeutics Corp

1.6B
Assets
547.5m
Liabilities
1.6B
Assets
547.5m
Liabilities
Current Assets 1.5B
Cash & Short-Term Investments 1.4B
Other Current Assets 72.3m
Non-Current Assets 73.4m
Other Non-Current Assets 73.4m
Current Liabilities 151.7m
Accrued Liabilities 7.1m
Other Current Liabilities 144.6m
Non-Current Liabilities 395.8m
Long-Term Debt 362.5m
Other Non-Current Liabilities 33.3m

Balance Sheet
Modalis Therapeutics Corp

Rotate your device to view
Balance Sheet
Currency: JPY
Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
1 205
3 857
5 421
4 936
2 933
1 883
Cash Equivalents
1 205
3 857
5 421
4 936
2 933
1 883
Total Receivables
5
7
0
0
0
0
Accounts Receivables
5
7
0
0
0
0
Other Receivables
0
0
0
0
0
0
Inventory
0
0
0
0
40
6
Other Current Assets
4
11
27
131
88
67
Total Current Assets
1 215
3 875
5 449
5 067
3 061
1 956
PP&E Net
1
49
50
224
0
0
Intangible Assets
0
0
768
705
0
0
Other Long-Term Assets
9
15
11
73
69
70
Total Assets
1 225
N/A
3 938
+222%
6 277
+59%
6 069
-3%
3 130
-48%
2 026
-35%
Liabilities
Accrued Liabilities
10
14
17
26
18
92
Short-Term Debt
0
0
0
0
0
0
Other Current Liabilities
13
77
41
155
124
106
Total Current Liabilities
23
91
58
181
142
198
Long-Term Debt
0
0
0
0
0
413
Deferred Income Tax
0
5
12
5
0
0
Other Liabilities
0
0
0
334
47
35
Total Liabilities
23
N/A
96
+322%
70
-27%
520
+641%
189
-64%
646
+242%
Equity
Common Stock
50
1 300
2 707
2 744
2 095
1 218
Retained Earnings
220
79
528
1 266
2 586
2 384
Additional Paid In Capital
1 372
2 622
4 029
4 066
3 417
2 539
Treasury Stock
0
0
0
0
0
0
Other Equity
0
0
2
5
16
7
Total Equity
1 202
N/A
3 843
+220%
6 207
+62%
5 549
-11%
2 941
-47%
1 380
-53%
Total Liabilities & Equity
1 225
N/A
3 938
+222%
6 277
+59%
6 069
-3%
3 130
-48%
2 026
-35%
Shares Outstanding
Common Shares Outstanding
20
25
29
29
29
33

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.